120 related articles for article (PubMed ID: 8533528)
1. Progressive mediastinal widening after therapy for Hodgkin's disease.
Michel F; Gilbeau JP; Six C; Michaux JL; Delannoy A
Acta Clin Belg; 1995; 50(5):282-7. PubMed ID: 8533528
[TBL] [Abstract][Full Text] [Related]
2. Mediastinal Hodgkin disease in children: response to therapy.
Luker GD; Siegel MJ
Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
[TBL] [Abstract][Full Text] [Related]
3. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
4. Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease.
Thomas F; Cosset JM; Cherel P; Renaudy N; Carde P; Piekarski JD
Radiother Oncol; 1988 Feb; 11(2):119-22. PubMed ID: 3353516
[TBL] [Abstract][Full Text] [Related]
5. Persistent mediastinal mass is not indicative of recurrence after chemotherapy only in paediatric Hodgkin's disease.
Van Den Berg H; Verhulst L; Behrendt H; Staalman CR
Br J Haematol; 2000 Apr; 109(1):104-8. PubMed ID: 10848788
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography in the diagnosis and treatment of mediastinal abnormalities in children.
Ivancev K; Halldorsdottir A; Laurin S; Sandström S; Békássy A; Garwics S; Wiebe T
Acta Radiol; 1988; 29(1):115-20. PubMed ID: 2964832
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging.
Nyman R; Forsgren G; Glimelius B
Acta Radiol; 1996 May; 37(3 Pt 1):323-6. PubMed ID: 8845262
[TBL] [Abstract][Full Text] [Related]
8. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
10. Thymic hyperplasia following successful treatment for nodular-sclerosing Hodgkin's disease.
Scheinpflug K; Schmitt J; Jentsch-Ullrich K; Roessner A; Franke A
Leuk Lymphoma; 2003 Sep; 44(9):1615-7. PubMed ID: 14565667
[TBL] [Abstract][Full Text] [Related]
11. Management of residual thymic cysts in patients treated for mediastinal Hodgkin's disease.
el-Sharkawi AM; Patel B
Thorax; 1995 Oct; 50(10):1118-9. PubMed ID: 7491566
[TBL] [Abstract][Full Text] [Related]
12. The significance of the residual mediastinal mass in treated Hodgkin's disease.
Jochelson M; Mauch P; Balikian J; Rosenthal D; Canellos G
J Clin Oncol; 1985 May; 3(5):637-40. PubMed ID: 3998780
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
Harris EW; Rakow JI; Weiner M; Agress H
J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
[TBL] [Abstract][Full Text] [Related]
14. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
Burns DE; Schiffman FJ
Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
[TBL] [Abstract][Full Text] [Related]
15. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
[TBL] [Abstract][Full Text] [Related]
16. Residual masses on follow-up computed tomography in patients with mediastinal non-Hodgkin's lymphoma.
Uematsu M; Kondo M; Tsutsui T; Murase T; Yorozu A; Hiramatsu H; Fujii H; Hashimoto S
Clin Radiol; 1989 May; 40(3):244-7. PubMed ID: 2752680
[TBL] [Abstract][Full Text] [Related]
17. Massive mediastinal Hodgkin's disease with calcification masquerading teratocarcinoma: differentiation by computed tomography.
Shin MS; Branscomb BV; Ho KJ
J Comput Tomogr; 1985 Oct; 9(4):321-7. PubMed ID: 4053660
[TBL] [Abstract][Full Text] [Related]
18. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.
Radford JA; Cowan RA; Flanagan M; Dunn G; Crowther D; Johnson RJ; Eddleston B
J Clin Oncol; 1988 Jun; 6(6):940-6. PubMed ID: 3373265
[TBL] [Abstract][Full Text] [Related]
19. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
[TBL] [Abstract][Full Text] [Related]
20. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
Brisse H; Pacquement H; Burdairon E; Plancher C; Neuenschwander S
Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
